Edit search
Anti-infliximab antibodies are already detectable in most pa…
Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle%3A an open-label pharmacokinetic cohort study
Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle%3A an open-label pharmacokinetic cohort study
Article, Chapter
Authors: B.J.F van den Bemt
Publication: Volume:12, Page(s):12-12
Published: 2011
Browse related articles
  Request a copy of this item
Cite this item